Cites del registre

Cita APA (7th ed.)
Hiroaki Konishi, P., Hajime Abe, M., Matsumoto, N., Endo, Y., Yoshiki Sekijima, M., Mitsuharu Ueda, M., & Yukio Ando, M. (2025). Real-World Utilization Patterns, Safety, and Efficacy of Tafamidis in Patients With Hereditary Transthyretin Amyloidosis in Japan. Elsevier.
Cita Chicago (17th ed.)
Hiroaki Konishi, PharmD, MD Hajime Abe, Noriko Matsumoto, Yutaka Endo, MD Yoshiki Sekijima, MD Mitsuharu Ueda, i MD Yukio Ando. Real-World Utilization Patterns, Safety, and Efficacy of Tafamidis in Patients With Hereditary Transthyretin Amyloidosis in Japan. Elsevier, 2025.
Cita MLA (9th ed.)
Hiroaki Konishi, PharmD, et al. Real-World Utilization Patterns, Safety, and Efficacy of Tafamidis in Patients With Hereditary Transthyretin Amyloidosis in Japan. Elsevier, 2025.
Atenció: Aquestes cites poden no estar 100% correctes.